NGS use is validated in 2025 American Urological Association guideline update, marking an important step towards more accurate and rapid urinary infection diagnostics. ORLANDO, FL / ACCESS Newswire / ...
NGS use is validated in 2025 American Urological Association guideline update, marking an important step towards more accurate and rapid urinary infection diagnostics. ORLANDO, FL / ACCESS Newswire / ...
Promoting interdisciplinary collaboration via molecular tumor boards and shared decision-making frameworks might improve the ...
Details: Two FFPE-derived DNA samples (colon and liver) alongside a high-quality genomic DNA control (NA12878) were used to ...
Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Explore the evolution of diagnostics in India from walk-in labs to predictive genomics. Learn how genomics, next-generation ...
Zacks.com on MSN
Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD
TEM secures FDA clearance for its xR IVD device, advancing RNA-based cancer research and precision medicine tools.
PFRDA, led by Sivasubramanian Ramann, plans to expand NPS investment options to include gold, silver, and AIFs.
Johnson & Johnson Vietnam has partnered with Ho Chi Minh City Oncology Hospital to improve treatment for lung and prostate cancers through the first memorandum of understanding (MoU) signed between ...
The convergence of biomarker-driven testing, AI-enabled diagnostics, and pharma-diagnostics partnerships are transforming how treatments are developed, prescribed, and delivered worldwide. NEW ...
Wisconsin Physicians Service Insurance Corporation aligned its coverage determination with fellow contractor Palmetto GBA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results